Meeting
2019 Gastrointestinal Cancers Symposium
Resection of primary tumor in liver only metastatic midgut neuroendocrine tumors.
Authors
Nicholas Manguso
Cedars-Sinai Medical Center, Los Angeles, CA
Nicholas Manguso , Jaewon Lee , Andrew Eugene Hendifar , Richard Tuli , Alexandra Gangi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 446)
DOI
10.1200/JCO.2019.37.4_suppl.446
Abstract #
446
Poster Bd #
P6
Abstract Disclosures
Similar Posters
Poster
2013 Gastrointestinal Cancers Symposium
Long-term survival after multidisciplinary treatment of small-bowel neuroendocrine tumors with synchronous liver metastases. A single-institute experience.
First Author: Emilio Bertani
Poster
2022 ASCO Gastrointestinal Cancers Symposium
A natural history of gastroenteropancreatic neuroendocrine tumors evaluated at a tertiary cancer center: An observational study of 2,067 cases.
First Author: Benjamin Daniel Powers
Poster
2021 Gastrointestinal Cancers Symposium
Real-world efficacy and safety of peptide receptor radionuclide therapy (PRRT) in gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
First Author: Estephany Abou Jokh Casas
Poster
2018 Gastrointestinal Cancers Symposium
Baseline factors associated with acute progression of metastatic lesions after primary tumor resection in patients with unresectable colorectal cancer.
First Author: Momoko Akashi